Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Entrada Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −5 vs. Q2 2022
- Shares held
- 24.5M
- −261.7K (−1.1%) vs. Q2 2022
- Total value
- $386.4M
- +$84.5M (+28.0%) vs. Q2 2022
- New holders
- 4
- 14 more added
- Sold out
- 9
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 165 | $3.00K | 0.00% | +52+46.0% | Added |
| BNP Paribas Arbitrage, SA | 198 | $3.12K | 0.00% | +198 | New |
| Advisor Group Holdings, Inc. | 300 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 1,005 | $16.0K | 0.00% | −869−46.4% | Reduced |
| Barclays PLC | 1,215 | $19.0K | 0.00% | +1,179+3,275.0% | Added |
| Citigroup Inc | 1,583 | $25.0K | 0.00% | +1,489+1,584.0% | Added |
| Tower Research Capital LLC (TRC) | 2,508 | $40.0K | 0.00% | +2,508 | New |
| Bank of America Corp | 3,966 | $63.0K | 0.00% | −9,025−69.5% | Reduced |
| Morgan Stanley | 10,530 | $166.0K | 0.00% | −10,655−50.3% | Reduced |
| Fred Alger Management, LLC | 17,955 | $283.0K | 0.00% | +17,955 | New |
| Northern Trust Corp | 29,997 | $473.0K | 0.00% | +13,669+83.7% | Added |
| State Street Corp | 33,294 | $525.0K | 0.00% | +3,100+10.3% | Added |
| Manufacturers Life Insurance Company, The | 41,175 | $640.0K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 59,496 | $925.0K | 0.00% | +1,821+3.2% | Added |
| Charles Schwab Investment Management Inc | 87,859 | $1.39M | 0.00% | +45,077+105.4% | Added |
| Invesco Ltd. | 95,209 | $1.50M | 0.00% | +95,209 | New |
| Moore Capital Management, LP | 105,000 | $1.66M | 0.05% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 141,593 | $2.23M | 1.42% | −31,989−18.4% | Reduced |
| BlackRock Inc. | 147,593 | $2.33M | 0.00% | +82,594+127.1% | Added |
| Geode Capital Management, LLC | 167,118 | $2.63M | 0.00% | +65,347+64.2% | Added |
| Laurion Capital Management LP | 199,066 | $3.14M | 0.09% | +70,000+54.2% | Added |
| Goldman Sachs Group Inc | 449,993 | $7.09M | 0.00% | +4,307+1.0% | Added |
| FMR LLC | 503,907 | $7.94M | 0.00% | −441,001−46.7% | Reduced |
| 72 Investment Holdings, LLC | 509,023 | $8.02M | 6.35% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 642,189 | $10.1M | 3.04% | −21,505−3.2% | Reduced |
| StepStone Group LP | 761,277 | $12.0M | 1.71% | +126,318+19.9% | Added |
| Vanguard Group Inc | 870,147 | $13.7M | 0.00% | +107,783+14.1% | Added |
| Wellington Management Group LLP | 1,007,246 | $15.9M | 0.00% | −528,637−34.4% | Reduced |
| Redmile Group, LLC | 1,954,419 | $30.8M | 1.19% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,972,050 | $46.8M | 0.01% | +534,552+21.9% | Added |
| 5AM Venture Management, LLC | 4,408,379 | $69.5M | 13.31% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,425,784 | $69.8M | 26.57% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,865,819 | $76.7M | 0.50% | 00.0% | Unchanged |
| CHI Advisors LLC | 0 | $0 | 0.00% | −163,496−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −106,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −76,498−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −18,807−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,947−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −597−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |